Factors Influencing Adherence to Adjuvant Endocrine Therapy
Launched by UNIVERSITY OF ZAGREB · Dec 20, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how well women adhere to adjuvant endocrine therapy (AET), a treatment that helps reduce the chances of breast cancer coming back. Specifically, the research aims to understand the factors that influence whether women take their medication as prescribed. By surveying women in Croatia who are undergoing this treatment, the study will look at their beliefs about the medicine, their quality of life, and how these factors relate to their adherence to therapy.
To be eligible for this study, participants need to be women over 18 years old who have been diagnosed with early-stage hormone receptor-positive breast cancer and have been on AET for more than three months. Unfortunately, women with advanced breast cancer or certain mental health issues cannot take part in this trial. Those who join can expect to complete an anonymous survey that will help researchers gather important information. This study is crucial as it will help develop better support for women undergoing AET, ultimately aiming to improve their treatment experience and outcomes.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • women older than 18 years of age
- • clinical diagnosis of hormone receptor positive early breast cancer stages 0-III according to the American Joint Committee on Cancer (AJCC) classification
- • prescribed with adjuvant endocrine therapy for more than 3 months
- Exclusion Criteria:
- • advanced metastatic breast cancer, stage IV according to the American Joint Committee on Cancer (AJCC) classification
- • other life-threatening illnesses
- • mental disorders
- • behavioral disorders caused by the use of psychoactive substances
- • behavioral syndromes related to physiological disorders and physical factors
- • cognitive impairment
- • organic and symptomatic mental disorder
- • schizophrenia
- • disorders similar to schizophrenia
- • delusional disorders
- • personality disorders
- • behavior disorders
- • mental retardation
- • psychological development disorders
- • unspecified mental disorders
- • Incapable of autonomously reaching decisions
About University Of Zagreb
The University of Zagreb, a leading academic institution in Croatia, is committed to advancing medical research and improving healthcare outcomes through innovative clinical trials. With a focus on interdisciplinary collaboration, the university harnesses its extensive expertise and state-of-the-art facilities to conduct rigorous clinical studies that address pressing health challenges. By fostering partnerships with healthcare professionals, industry leaders, and regulatory bodies, the University of Zagreb aims to translate scientific discoveries into practical applications, ultimately enhancing patient care and contributing to the global body of medical knowledge.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zagreb, , Croatia
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported